Actively Recruiting
Erector Spinae Plane Block for Children Undergoing Thoracoscopic Sympathectomy: A Prospective Controlled Trial
Led by Menoufia University · Updated on 2025-05-22
40
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate how ultrasound-guided erector spinae plane block influences postoperative pain and diaphragm function in children aged 6 to 16 years undergoing thoracoscopic sympathectomy. The study addresses pain management challenges after pediatric thoracic surgery, which can negatively affect recovery by reducing cough strength and increasing the risk of lung complications like atelectasis and pneumonia. Erector spinae plane block is a newer regional anesthesia technique being studied for its potential to improve postoperative pain control in this setting. Participants are randomly assigned to one of two groups: the study group receives bilateral erector spinae plane block after general anesthesia is induced, while the control group receives general anesthesia without the block. Both groups undergo bilateral thoracoscopic sympathectomy under general anesthesia, and the study compares outcomes related to pain relief and diaphragmatic function. During the study, researchers will monitor pain levels, total analgesic and anesthetic use, diaphragm movement, timing of rescue pain medication, complication rates, and recovery profiles within 24 hours after surgery. The trial uses double-blinding to reduce bias. Participant involvement includes standard anesthesia and surgery procedures, with additional assessments to measure the effects of the erector spinae plane block on postoperative recovery and safety over the first day following surgery.
CONDITIONS
Brief Title
Erector Spinae Plane Block for Children Undergoing Thoracoscopic Sympathectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age from 6 to 16 years
- Either sexes (male or female)
- American Society of Anesthesiologists (ASA) physical status I-II
- Scheduled for bilateral thoracoscopic sympathectomy under general anesthesia
You will not qualify if you...
- History of allergy to local anesthetics
- Abnormal liver or kidney function
- Severe spinal deformities
- Bleeding or coagulation disorders
- Skin damage or infection at the proposed puncture site
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants undergo bilateral thoracoscopic sympathectomy under general anesthesia. Those in the study group receive an erector spinae plane block after induction of anesthesia to manage postoperative pain.
1 surgery visit (in-person)
Duration - 24 hours postoperatively
Participants are monitored for pain levels, analgesic consumption, diaphragmatic excursion, recovery profile, and complications after surgery.
1 follow-up visit (in-person) within 24 hours after surgery
Trial Site Locations
Total: 1 location
1
Menoufia University
Shibīn al Kawm, Menoufia, Egypt, 32511
Actively Recruiting
Research Team
S
Safaa M Sallam, Master
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here